PEPTAI Price Swings Wild As Base Integration Fuels DeSci Hype

Story Highlights* PEPTAI surged to nearly $2.50 before retracing toward $0.90 on Dexscreener.

  • The project uses autonomous AI agents for peptide drug discovery and IP automation.
  • Base integration increased visibility as DeSci narratives gain market traction.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned